Need for Salvage Therapies in R/R NHL – OncLive
OncLive |
Need for Salvage Therapies in R/R NHL
OncLive Stephen J. Schuster, MD: I think as David said, and broadly speaking, probably our current therapies prior to the introduction of CAR T-cells were successful in about half of patients, and in the other half, we need something else. Certainly, since the … |
